Spark Investment Management LLC Avenue Therapeutics, Inc. Transaction History

Spark Investment Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 11, 2020	SELL	$5.26 - $9.6 $77,316 - $141,110	-14,699 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$5.58 - $6.3 $49,109 - $55,446	-8,801 Reduced 37.45%	14,699 $87,000
Q2 2019 Aug 12, 2019	SELL	$4.33 - $6.54 $30,310 - $45,780	-7,000 Reduced 22.95%	23,500 $148,000
Q1 2019 May 07, 2019	BUY	$4.75 - $6.59 $144,875 - $200,995	30,500 New	30,500 $144,000
Q4 2017 Feb 12, 2018	SELL	$3.53 - $5.64 $44,100 - $70,460	-12,493 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$5.08 - $6.68 $63,464 - $83,453	12,493	12,493 $69,000

Ticker ATXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,127,720
Market Cap $9.25M
Description
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was in...

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Spark Investment Management LLC with notifications on news.